Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO

A US listing for the oncology specialist continues a bumper year for biotech IPOs.

Source: Pharmaceutical Technology, 2026-10-09. Third-party report, linked to its original publisher; IC360 has not independently verified it.